The first recombinant vaccine for humans, a vaccine for hepatitis B, was approved
In May 1986, the vaccine Recombivax HB, which protects against hepatitis B infection, was approved for marketing in…
In May 1986, the vaccine Recombivax HB, which protects against hepatitis B infection, was approved for marketing in…
In 1986, while teaching a graduate course at the University of Alberta, Dr. Tyrrell found clues that might…
On Sept. 1, 1984, with the enactment of P.L. 98-369 by the U.S. Congress, coverage under Part B…
In 1982, the first hepatitis B viral vaccines, developed by Merck and also by the Pasteur Institute, were…
In 1981, the U.S. Food and Drug Administration (FDA) approved a plasma-derived hepatitis B vaccine for human use….
In 1974, Stanford Medicine researchers isolated the genome of a virus that causes hepatitis B and a common…
In 1974, the Expanded Programme on Immunization was created within WHO, in response to poor immunization levels in…
In 1971, the testing of donated blood for Hepatitis B surface antigen began. The hepatitis B virus was…
In 1971, the U.S. Centers for Disease Control and Prevention (CDC) discovered that hepatitis B is sexually transmitted….
In 1947, after almost 10 years of inquiry into the nature of this illness, F.O. MacCallum, a British…